3 Stocks Primed for a Short Squeeze
Let the bears' folly line your pockets in coming weeks
Click to Enlarge Operating in the biotech arena, Ilumina (ILMN) markets life science tools and other systems for biological and gene analysis.
Biotech stocks have been hit of lately as this market-leading sector got a little too lofty for some traders. During the recent weakness, ILMN consolidated just above $90 and is now heading to break through $100.
The move above $100 likely will get the growing shorts to blink, sparking a short squeeze that should result in a breakaway above $100.
Article printed from InvestorPlace Media, http://investorplace.com/2013/11/3-short-squeeze-crm-gme-ilmn/.
©2016 InvestorPlace Media, LLC